Grants per year
Search results
-
Finished
Prot #CAB-201-002: A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T cells (CABA-201) in Subjects with Active Idiopathic Inflammatory Myopathy
Georges, G. E. (PD/PI), Hsieh, C. (PD/PI) & Hsieh, C. (Co-Investigator)
Advanced Clinical LLC, Cabaletta Bio, Inc.
1/22/24 → 5/21/24
Project: Research project